[230 Pages Report] The Cell Viability Assays Market was valued at USD 2.54 billion in 2017 and is expected to reach USD 4.16 billion by 2023, at a CAGR of 8.4% during the forecast period. The base year considered for the study is 2017 and the forecast period is 2018 to 2023.

                                                             –> Global Industry Segmentation <–

By product, the consumables segment is expected to account for the largest share of the cell viability assays market in 2018

On the basis of product, the consumables segment is expected to account for the largest share of the cell viability assays market in 2018. This large share can be attributed to the repeated consumption of consumables in various cell viability procedures. The growing focus on stem cell and cancer research is another major driver for the growth of the cell viability consumables market along with the growing application of cell viability in quality control procedures in various industries, such as food and beverage, pharmaceutical, biotechnology products manufacturing, environmental monitoring, and water treatment.

By application, the drug discovery & development application segment is estimated to hold the largest share in 2018

Based on application, the cell viability assays market is segmented into drug discovery & development, basic research, stem cell research, clinical & diagnostic applications, and other applications. In 2018, the drug discovery & development application segment is expected to account for the largest share of the global cell viability assays market. The large share of this segment can be attributed to the rising incidence and prevalence of chronic and infectious diseases and increasing government support for developing new treatments for various human diseases.

By end user, the pharmaceutical and biotechnology companies segment is estimated to hold the largest share of the cell viability assays market in 2018

On the basis of end user, the cell viability assays market is segmented into pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, academic and research institutes, and other end users (food and beverage companies and environmental testing companies). The pharmaceutical and biotechnology companies segment is expected to account for the largest share in 2018. The large share of this segment can be attributed to the increasing number of R&D activities undertaken by these companies for the development of biopharmaceutical products.

Read More Detailed Information, Here | Download the PDF Brochure

North America to dominate the market in 2018

North America is expected to account for the largest share of the cell viability assays market in 2018, followed by Europe and Asia Pacific. The growing incidence rate of various infectious diseases, investment initiatives by the government, and the high-quality infrastructure for clinical and laboratory research are the major factors responsible for the large share of the North American cell viability assays market. Moreover, a number of major global players are based in the US, owing to which, the US is a center for innovation in the cell viability assays market.

Objectives of the Study:

• To define, describe, segment, and forecast the global cell viability assays market by product, application, cell type, end user, and region
• To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
• To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
• To forecast the size of the cell viability assays market in five main regions (along with major countries) North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
• To profile key players in the global cell viability assays market and comprehensively analyze their core competencies and market shares
• To track and analyze competitive developments such as mergers and acquisitions; new product/technology launches; expansions; collaborations and agreements; and R&D activities of the leading players in the global cell viability assays market

Research Methodology:

Top-down and bottom-up approaches were used to validate the size of the global cell viability assays market and estimate the size of other dependent submarkets. Various secondary sources such as directories; industry journals; databases such as D&B Hoovers, Bloomberg Business, and Factiva; and annual reports of companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both the supply and demand sides have been interviewed to obtain and validate information as well as to assess the dynamics of this market. The breakdown of primary profiles is shown in the figure below:

                              You Can Also Ask to Get 10% FREE Customization on This Report

The prominent players in the global cell viability assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), GE Healthcare (US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), G-Biosciences (US), Creative Bioarray (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).

Target Audience:

• Manufacturers of cell viability instruments and consumables
• Distributors of cell viability instruments and consumables
• Research and development organizations
• Hospitals and clinics
• Diagnostic centers
• Market research and consulting firms
• Venture capitalists and investors

Scope of the Report:

The research report categorizes the market into the following segments and subsegments:

Cell Viability Assays Market, By Product

• Consumables
  • Reagents
  • Assay Kits
    • Tetrazolium Reduction Assay Kits
      • MTT Assay Kits
      • Other Tetrazolium Assay Kits
    • Resazurin Cell Viability Assay Kits
    • Calcein-AM Cell Viability Assay Kits
    • Other Assay Kits
  • Microplates
• Instruments
  • Spectrophotometers
  • Flow Cytometers
  • Automated Cell Counters
  • Cell Imaging & Analysis Systems

Cell Viability Assays Market, By Application

• Basic Research
• Stem Cell Research
• Drug Discovery & Development
• Clinical & Diagnostic Applications
• Other Applications

Cell Viability Assays Market, By End User

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Hospital and Diagnostic Laboratories
• Other End Users

Cell Viability Assays Market, by Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa